We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDR
3201
DELISTED
Waddell & Reed Financial, Inc.
WDR
-206,399
Closed -$5.17M
GLUU
3202
DELISTED
Glu Mobile Inc.
GLUU
-425,901
Closed -$5.32M
RP
3203
DELISTED
RealPage, Inc.
RP
-91,799
Closed -$8.01M
GNMK
3204
DELISTED
GenMark Diagnostics, Inc
GNMK
-98,289
Closed -$2.35M
EGOV
3205
DELISTED
NIC Inc
EGOV
-218,449
Closed -$7.41M
IPHI
3206
DELISTED
INPHI CORPORATION
IPHI
-49,490
Closed -$8.83M
FPRX
3207
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-53,509
Closed -$2.02M
VAR
3208
DELISTED
Varian Medical Systems, Inc.
VAR
-181,875
Closed -$32.1M
MIK
3209
DELISTED
Michaels Stores, Inc
MIK
-254,187
Closed -$5.58M
PS
3210
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-120,474
Closed -$2.69M
PAND
3211
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
-12,368
Closed -$743K
HMSY
3212
DELISTED
HMS Holdings Corp.
HMSY
-102,702
Closed -$3.8M
AVEO
3213
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-20,004
Closed -$146K
CFRX
3214
DELISTED
ContraFect Corporation
CFRX
-213
Closed -$82K
TCF
3215
DELISTED
TCF Financial Corporation Common Stock
TCF
-425,711
Closed -$19.8M
GTT
3216
DELISTED
GTT Communications, Inc.
GTT
-45,844
Closed -$84K
UCBH
3217
DELISTED
UCBH HOLDINGS INC
UCBH
$0 ﹤0.01%
14,002
CNB
3218
DELISTED
COLONIAL BANCGROUP INC
CNB
$0 ﹤0.01%
23,800
PFSW
3219
DELISTED
PFSweb, Inc.
PFSW
-12,741
Closed -$86K
CEMI
3220
DELISTED
Chembio diagnostics, Inc.
CEMI
-17,866
Closed -$63K
GFN
3221
DELISTED
General Finance Corporation
GFN
-16,462
Closed -$200K
CKH
3222
DELISTED
Seacor Holdings Inc.
CKH
-66,140
Closed -$2.69M
MTSC
3223
DELISTED
MTS Systems Corp
MTSC
-71,003
Closed -$4.13M
LJPC
3224
DELISTED
La Jolla Pharmaceutical Company
LJPC
-24,411
Closed -$104K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.